Voyager Therapeutics Inc (FRA:VT6)
€ 5.405 0.01 (0.19%) Market Cap: 300.98 Mil Enterprise Value: 14.99 Mil PE Ratio: 8.89 PB Ratio: 0.95 GF Score: 62/100

Q4 2020 Voyager Therapeutics Inc Earnings Call Transcript

Feb 25, 2021 / 09:30PM GMT
Release Date Price: €5.25 (-4.55%)
Operator

Good afternoon, and welcome to the Voyager Therapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. (Operator Instructions) This call is being webcast live on the Investor & Media section of Voyager's website at voyagertherapeutics.com. This call is the property of Voyager Therapeutics, and recording, reproduction or transmission of this call without the express written consent of Voyager Therapeutics is strictly prohibited. Please be advised that this call is being recorded.

I would now like to introduce Allison Dorval, CFO at Voyager.

Allison Dorval
Voyager Therapeutics, Inc. - CFO & Principal Accounting Officer

Good afternoon, and thank you for joining us. With me on the call today are Andre Turenne, our President and Chief Executive Officer; and Omar Khwaja, Chief Medical Officer and Head of R&D.

This afternoon after market close, we issued a press release, which outlines the financial results and corporate highlights for the fourth quarter and full year 2020. The release is available at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot